Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Increased aggregation tendency of alpha-synuclein in a fully disordered protein complex.
J. Mol. Biol. 431, 2581-2598 (2019)
The recent discovery of biologically active fully disordered, so called random fuzzy protein protein interactions leads to the question of how the high flexibility of these protein complexes correlates to aggregation and pathologic misfolding.We identify the structural mechanism by which a random fuzzy protein complex composed of the intrinsically disordered proteins alpha-Synuclein and SERF1a is able to potentiate cytotoxic aggregation. A structural model derived from an integrated NMR/SAXS analysis of the reconstituted aSyn:SERF1a complex enabled us to observe the partial deprotection of one precise aSyn amyloid nucleation element in the fully unstructured ensemble. This minimal exposure was sufficient to increase the amyloidogenic tendency of SERF1a-bound aSyn.Our findings provide a structural explanation of the previously observed pro-amyloid activity of SERF1a. They further demonstrate that random fuzziness can trigger a structurally organized disease-associated reaction such as amyloid polymerization.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.067
1.243
7
7
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Fuzzy Complexes ; Intrinsically Disordered Proteins ; Amyloids ; Alpha Synuclein ; Moag-4/serf; Nmr; Promotes; Mechanism; Dynamics; Binding; Order
Sprache
Veröffentlichungsjahr
2019
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0022-2836
e-ISSN
1089-8638
Zeitschrift
Journal of Molecular Biology
Quellenangaben
Band: 431,
Heft: 14,
Seiten: 2581-2598
Verlag
Elsevier
Verlagsort
24-28 Oval Rd, London Nw1 7dx, England
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Structural Biology (STB)
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503000-001
WOS ID
WOS:000474681400009
Scopus ID
85065793752
PubMed ID
31034892
Erfassungsdatum
2019-05-14